SIBN.NASDAQSi-bone, INC

Form 4: SI-BONE Director Greg Hinckley Trades Shares

Sentiment:

Statement of Changes in Beneficial Ownership


SI-BONE, Inc. reports a Form 4 filing detailing stock transactions by Director Greg K. Hinckley.

Summary

  • Director Greg K. Hinckley acquired 3,085 shares of SI-BONE, Inc. common stock on April 7, 2026, at a price of $5.94 per share.
  • Following this transaction, Mr. Hinckley beneficially owns 105,135 shares directly.
  • The filing also notes the disposition of 75,603 shares held as community property with the right of survivorship by Gregory K. Hinckley and Mary C. Hinckley.
  • Additionally, the filing references a stock option for 3,085 shares with an exercise price of $5.94, acquired on April 7, 2026, with vesting over three years starting October 17, 2018.
  • The report includes 8,675 shares issuable upon settlement of restricted stock units.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it primarily reports routine insider transactions without providing new strategic or financial performance information.

Positives

  • Director acquisition of shares can signal confidence in the company's future prospects.
  • The acquisition of 3,085 shares at $5.94 per share indicates a belief in the current valuation or potential upside.

Negatives

  • The disposition of 75,603 shares by the director's community property could be interpreted as a reduction in direct beneficial ownership, though the exact reasons are not specified.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance regarding future financial performance. The details pertain to past transactions and current beneficial ownership.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The specific details of this filing, including the acquisition and disposition of shares by a director, are common within the biotechnology and medical device sectors where SI-BONE operates, reflecting typical compensation structures and insider investment activities.

Stakeholder Impact

  • Shareholders: The acquisition of shares by a director may be viewed positively, suggesting insider confidence. The disposition of shares by community property could raise questions about the extent of insider selling, though it may be for personal financial planning unrelated to company performance.

Key Dates

DateDescription
04/07/2026Transaction Date for acquisition of common stock and stock option.
10/17/2018Commencement date for vesting of stock options.
04/09/2026Date of signature for the filing.

Keywords

SI-BONE, SIBN, Form 4, SEC Filing, Insider Trading, Stock Options, Restricted Stock Units, Director Transactions, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.